Asceneuron
FranceEntry
2020
Hold
6yr
Status
Active
Who owns Asceneuron?
Asceneuron is a French Biotech company, currently owned by Novo Holdings since 2024 and Sofinnova Partners.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Sofinnova PartnersSofinnova Capital IX · 2018 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2020 · present
Sofinnova PartnersActive
2020 · present(6yr) · Sofinnova Capital IX · 2018 · Life Sciences VC
Novo HoldingsActive
2024 · present(2yr) · Novo Holdings Venture Investments · 1999 · VC
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
US
Italy
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Asceneuron?
Asceneuron is currently owned by Novo Holdings and Sofinnova Partners, through Sofinnova Capital IX, since 2024.
When did Novo Holdings and 1 other acquire Asceneuron?
Novo Holdings and 1 other acquired Asceneuron in 2024.
Who has owned Asceneuron over time?
Asceneuron has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital IX · since 2020; Novo Holdings · via Novo Holdings Venture Investments · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue